Literature DB >> 30295691

Direct monitoring of the conformational equilibria of the activation loop in the mitogen-activated protein kinase p38α.

Patrick Roser1, Jörn Weisner, Jeffrey R Simard, Daniel Rauh, Malte Drescher.   

Abstract

Conformational transitions in protein kinases are crucial for the biological function of these enzymes. Here, we characterize and assess conformational equilibria of the activation loop and the effect of small molecule inhibitors in the MAP kinase p38α. Our work experimentally revealed the existence of a two-state equilibrium for p38α while the addition of inhibitors shifts the equilibrium between these two states.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30295691     DOI: 10.1039/c8cc06128a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

1.  Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2.

Authors:  Laurel M Pegram; Jennifer C Liddle; Yao Xiao; Maria Hoh; Johannes Rudolph; Dylan B Iverson; Guy P Vigers; Darin Smith; Hailong Zhang; Weiru Wang; John G Moffat; Natalie G Ahn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

2.  Ligand discrimination between active and inactive activation loop conformations of Aurora-A kinase is unmodified by phosphorylation.

Authors:  James A H Gilburt; Paul Girvan; Julian Blagg; Liming Ying; Charlotte A Dodson
Journal:  Chem Sci       Date:  2019-03-04       Impact factor: 9.825

3.  Activation Loop Dynamics Are Coupled to Core Motions in Extracellular Signal-Regulated Kinase-2.

Authors:  Dylan B Iverson; Yao Xiao; David N Jones; Elan Z Eisenmesser; Natalie G Ahn
Journal:  Biochemistry       Date:  2020-07-15       Impact factor: 3.162

4.  Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced in vivo antitumor cancer therapy in nursing care.

Authors:  Zhe Zhou
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.